Enovix (NASDAQ:ENVX) Reaches New 1-Year Low – What’s Next?

Enovix Corporation (NASDAQ:ENVX) reached a new 52-week low during trading on Wednesday . The stock traded as low as $3.85 and last traded at $3.97, with a volume of 8363703 shares trading hands. The stock had previously closed at $4.23.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on the stock. JPMorgan Chase & Co. cut shares of Enovix from a “neutral” rating to an “underweight” rating in a research note on Wednesday, May 6th. Benchmark reduced their target price on shares of Enovix from $25.00 to $15.00 and set a “buy” rating for the company in a report on Thursday, May 14th. Craig Hallum decreased their price target on shares of Enovix from $10.00 to $8.00 and set a “buy” rating on the stock in a research report on Thursday, May 14th. Wall Street Zen upgraded shares of Enovix from a “strong sell” rating to a “sell” rating in a research report on Saturday, May 16th. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of Enovix in a research note on Wednesday, July 8th. Six investment analysts have rated the stock with a Buy rating, two have given a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat.com, Enovix has an average rating of “Hold” and a consensus price target of $12.50.

Enovix Stock Down 6.1%

The company has a quick ratio of 10.65, a current ratio of 10.97 and a debt-to-equity ratio of 2.14. The company has a fifty day simple moving average of $6.14 and a 200-day simple moving average of $6.17. The firm has a market cap of $866.06 million, a P/E ratio of -4.78 and a beta of 2.26.

Enovix (NASDAQ:ENVX) last posted its quarterly earnings data on Wednesday, May 13th. The company reported ($0.14) EPS for the quarter, topping the consensus estimate of ($0.15) by $0.01. Enovix had a negative return on equity of 64.28% and a negative net margin of 499.64%.The firm had revenue of $7.60 million for the quarter, compared to the consensus estimate of $6.95 million. During the same quarter last year, the company earned ($0.15) earnings per share. The business’s revenue for the quarter was up 49.1% compared to the same quarter last year. Enovix has set its Q2 2026 guidance at -0.170–0.130 EPS. On average, equities analysts anticipate that Enovix Corporation will post -0.79 earnings per share for the current year.

Institutional Investors Weigh In On Enovix

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Private Advisor Group LLC increased its holdings in Enovix by 2.7% during the 3rd quarter. Private Advisor Group LLC now owns 46,519 shares of the company’s stock worth $464,000 after purchasing an additional 1,242 shares during the period. Parallel Advisors LLC lifted its holdings in shares of Enovix by 51.9% in the 3rd quarter. Parallel Advisors LLC now owns 3,926 shares of the company’s stock worth $39,000 after buying an additional 1,342 shares during the period. Equitable Holdings Inc. lifted its holdings in shares of Enovix by 10.9% in the 3rd quarter. Equitable Holdings Inc. now owns 13,700 shares of the company’s stock worth $137,000 after buying an additional 1,342 shares during the period. NewEdge Advisors LLC grew its position in shares of Enovix by 4.7% during the 1st quarter. NewEdge Advisors LLC now owns 41,460 shares of the company’s stock worth $215,000 after buying an additional 1,853 shares in the last quarter. Finally, Mariner LLC grew its position in shares of Enovix by 3.4% during the 3rd quarter. Mariner LLC now owns 58,343 shares of the company’s stock worth $582,000 after buying an additional 1,921 shares in the last quarter. Institutional investors own 50.92% of the company’s stock.

Enovix Company Profile

Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.